VI
CCCC icon

Vestcor Inc’s C4 Therapeutics CCCC Stock Holding History

Vestcor Inc’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,500
Closed -$168K – 1208
2024
Q3 		$168K Buy
+29,500
New +$178K 0.01% 989

Other funds holding CCCC

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vestcor Inc's CCCC Position: Q4 2024 in Review

Vestcor Inc sold out of C4 Therapeutics (CCCC) in Q4 2024, closing a stake of 29,500 shares — an estimated $168K sold.

Vestcor Inc first reported a position in CCCC in Q3 2024 and held it in 1 quarter. The position peaked at $168K in Q3 2024. 113 funds tracked by Wall St. Rank hold CCCC as of Q4 2024.

  • Vestcor Inc reported no remaining C4 Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Vestcor Inc sold 29,500 C4 Therapeutics shares in Q4 2024, an estimated $168K.
  • Vestcor Inc first reported a position in C4 Therapeutics in Q3 2024 and held it in 1 quarter.
  • Vestcor Inc's C4 Therapeutics position peaked at $168K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2024.

Based on Vestcor Inc's 13F filing for Q4 2024, filed 10 Feb 2025.